Schizophrenia Trials in Hoffman Estates, United States
Conditions / Schizophrenia / Hoffman Estates, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
78 total trials for this combination
Showing top 10 of 78 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01192906 | A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) | COMPLETED | PHASE3 |
| NCT00034905 | A Comparison of Seroquel vs. Risperidone in Schizophrenia | COMPLETED | PHASE4 |
| NCT00641745 | Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia | COMPLETED | PHASE3 |
| NCT03893825 | A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia | COMPLETED | PHASE3 |
| NCT01235585 | A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) | COMPLETED | PHASE3 |
| NCT03345342 | A Study of Paliperidone Palmitate 6-Month Formulation | COMPLETED | PHASE3 |
| NCT02161718 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | COMPLETED | PHASE2 |
| NCT00325689 | Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. | COMPLETED | PHASE4 |
| NCT02970305 | Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) | COMPLETED | PHASE2 |
| NCT00731549 | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia | COMPLETED | PHASE3 |